$187 Million is the total value of Iguana Healthcare Management, LLC's 62 reported holdings in Q3 2014. The portfolio turnover from Q2 2014 to Q3 2014 was 84.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BIIB | Buy | BIOGEN IDEC INC | $14,059,000 | +17.3% | 42,500 | +11.8% | 7.51% | +34.4% |
| GILD | Buy | GILEAD SCIENCES INC | $12,508,000 | +101.1% | 117,500 | +56.7% | 6.68% | +130.3% |
| AMGN | Sell | AMGEN INC | $11,448,000 | +17.2% | 81,500 | -1.2% | 6.12% | +34.2% |
| MDT | Sell | MEDTRONIC INC | $8,518,000 | -12.4% | 137,500 | -9.8% | 4.55% | +0.3% |
| ABBV | Buy | ABBVIE INC | $7,220,000 | +50.5% | 125,000 | +47.1% | 3.86% | +72.3% |
| CELG | Sell | CELGENE CORP | $7,109,000 | -21.2% | 75,000 | -28.6% | 3.80% | -9.7% |
| New | SELECT SECTOR SPDR TRput | $6,391,000 | – | 100,000 | +100.0% | 3.41% | – | |
| SUPN | Buy | SUPERNUS PHARMACEUTICALS INC | $5,215,000 | +27.0% | 600,000 | +60.0% | 2.79% | +45.4% |
| ZBH | New | ZIMMER HLDGS INC | $5,028,000 | – | 50,000 | +100.0% | 2.69% | – |
| MRK | Sell | MERCK & CO INC NEW | $4,742,000 | -44.4% | 80,000 | -45.8% | 2.53% | -36.4% |
| TRNX | Buy | TORNIER N V | $4,183,000 | +43.1% | 175,000 | +40.0% | 2.23% | +63.9% |
| GWPH | Buy | GW PHARMACEUTICALS PLCads | $4,043,000 | -11.3% | 50,000 | +17.6% | 2.16% | +1.6% |
| AERI | Buy | AERIE PHARMACEUTICALS INC | $3,931,000 | +8.9% | 190,000 | +30.4% | 2.10% | +24.8% |
| MYL | Sell | MYLAN INC | $3,639,000 | -32.8% | 80,000 | -23.8% | 1.94% | -23.0% |
| New | REGENERON PHARMACEUTICALSput | $3,605,000 | – | 10,000 | +100.0% | 1.93% | – | |
| ISIS | Sell | ISIS PHARMACEUTICALS INC | $3,300,000 | -29.0% | 85,000 | -37.0% | 1.76% | -18.8% |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $3,255,000 | +73.5% | 57,500 | +37.6% | 1.74% | +98.7% |
| New | UNITED THERAPEUTICS CORP DEL | $3,216,000 | – | 25,000 | +100.0% | 1.72% | – | |
| RCPT | New | RECEPTOS INC | $3,106,000 | – | 50,000 | +100.0% | 1.66% | – |
| ESPR | ESPERION THERAPEUTICS INC NE | $3,058,000 | +54.4% | 125,000 | 0.0% | 1.63% | +76.7% | |
| SPNC | Sell | SPECTRANETICS CORP | $3,056,000 | +6.9% | 115,000 | -8.0% | 1.63% | +22.3% |
| New | PFIZER INC | $2,957,000 | – | 100,000 | +100.0% | 1.58% | – | |
| ETRM | Buy | ENTEROMEDICS INC | $2,884,000 | +208.1% | 2,344,000 | +290.7% | 1.54% | +252.4% |
| New | SANOFIcall | $2,822,000 | – | 50,000 | +100.0% | 1.51% | – | |
| HZNP | New | HORIZON PHARMA PLC | $2,702,000 | – | 220,000 | +100.0% | 1.44% | – |
| AVNR | Sell | AVANIR PHARMACEUTICALS INCcl a new | $2,682,000 | +90.2% | 225,000 | -10.0% | 1.43% | +117.8% |
| DXCM | New | DEXCOM INC | $2,600,000 | – | 65,000 | +100.0% | 1.39% | – |
| T107PS | WRIGHT MED GROUP INC | $2,576,000 | -3.5% | 85,000 | 0.0% | 1.38% | +10.5% | |
| ALKS | Sell | ALKERMES PLC | $2,572,000 | -39.9% | 60,000 | -29.4% | 1.37% | -31.2% |
| THC | Sell | TENET HEALTHCARE CORP | $2,524,000 | -36.7% | 42,500 | -50.0% | 1.35% | -27.6% |
| Sell | AMGEN INCcall | $2,458,000 | -16.9% | 17,500 | -30.0% | 1.31% | -4.9% | |
| PBYI | Sell | PUMA BIOTECHNOLOGY INC | $2,386,000 | +31.5% | 10,000 | -63.6% | 1.27% | +50.4% |
| New | MERCK & CO INC NEWput | $2,371,000 | – | 40,000 | +100.0% | 1.27% | – | |
| SLXP | Sell | SALIX PHARMACEUTICALS INC | $2,344,000 | -30.9% | 15,000 | -45.5% | 1.25% | -20.9% |
| ASPX | New | AUSPEX PHARMACEUTICALS INC | $2,310,000 | – | 90,000 | +100.0% | 1.23% | – |
| CMRX | New | CHIMERIX INC | $2,072,000 | – | 75,000 | +100.0% | 1.11% | – |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $1,944,000 | -43.3% | 150,000 | -28.6% | 1.04% | -35.1% |
| ELGX | Sell | ENDOLOGIX INC | $1,935,000 | -34.8% | 182,500 | -6.4% | 1.03% | -25.3% |
| DYAX | Buy | DYAX CORP | $1,872,000 | +66.0% | 185,000 | +57.4% | 1.00% | +90.1% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $1,804,000 | -10.8% | 25,000 | -23.1% | 0.96% | +2.2% |
| AGN | New | ALLERGAN INC | $1,782,000 | – | 10,000 | +100.0% | 0.95% | – |
| LJPC | Buy | LA JOLLA PHARMACEUTICAL CO | $1,730,000 | +88.5% | 180,000 | +80.0% | 0.92% | +115.9% |
| NVDQ | Buy | NOVADAQ TECHNOLOGIES INC | $1,586,000 | -19.8% | 125,000 | +4.2% | 0.85% | -8.2% |
| PETX | New | ARATANA THERAPEUTICS INC | $1,506,000 | – | 150,000 | +100.0% | 0.80% | – |
| ARWR | New | ARROWHEAD RESH CORP | $1,330,000 | – | 90,000 | +100.0% | 0.71% | – |
| OSUR | New | ORASURE TECHNOLOGIES INC | $1,264,000 | – | 175,000 | +100.0% | 0.68% | – |
| ELOS | New | SYNERON MEDICAL LTD | $1,202,000 | – | 120,000 | +100.0% | 0.64% | – |
| IPXL | Sell | IMPAX LABORATORIES INC | $1,186,000 | -47.3% | 50,000 | -33.3% | 0.63% | -39.6% |
| New | CELLDEX THERAPEUTICS INC NEWcall | $972,000 | – | 75,000 | +100.0% | 0.52% | – | |
| FLXN | FLEXION THERAPEUTICS INC | $913,000 | +35.5% | 50,000 | 0.0% | 0.49% | +55.4% | |
| CBAY | New | CYMABAY THERAPEUTICS INC | $855,000 | – | 125,000 | +100.0% | 0.46% | – |
| SNY | New | SANOFIsponsored adr | $846,000 | – | 15,000 | +100.0% | 0.45% | – |
| P103PS | Sell | NPS PHARMACEUTICALS INC | $845,000 | -51.3% | 32,500 | -38.1% | 0.45% | -44.3% |
| New | GW PHARMACEUTICALS PLCcall | $809,000 | – | 10,000 | +100.0% | 0.43% | – | |
| New | WRIGHT MED GROUP INCcall | $758,000 | – | 25,000 | +100.0% | 0.40% | – | |
| XLRN | Sell | ACCELERON PHARMA INC | $756,000 | -79.8% | 25,000 | -77.3% | 0.40% | -76.8% |
| New | AGIOS PHARMACEUTICALS INCput | $614,000 | – | 10,000 | +100.0% | 0.33% | – | |
| New | TORNIER N Vcall | $598,000 | – | 25,000 | +100.0% | 0.32% | – | |
| VNDA | Sell | VANDA PHARMACEUTICALS INC | $519,000 | -67.9% | 50,000 | -50.0% | 0.28% | -63.3% |
| ASMB | New | ASSEMBLY BIOSCIENCES INC | $410,000 | – | 50,000 | +100.0% | 0.22% | – |
| EGLTQ | Sell | EGALET CORP | $200,000 | -79.7% | 35,000 | -53.3% | 0.11% | -76.7% |
| New | ENTEROMEDICS INCcall | $87,000 | – | 70,000 | +100.0% | 0.05% | – | |
| MSTX | Exit | MAST THERAPEUTICS INC | $0 | – | -500,000 | -100.0% | -0.15% | – |
| FLML | Exit | FLAMEL TECHNOLOGIES SAsponsored adr | $0 | – | -25,000 | -100.0% | -0.18% | – |
| Exit | SUNSHINE HEART INCcall | $0 | – | -75,000 | -100.0% | -0.20% | – | |
| SSH | Exit | SUNSHINE HEART INC | $0 | – | -100,000 | -100.0% | -0.26% | – |
| Exit | DEPOMED INCput | $0 | – | -50,000 | -100.0% | -0.32% | – | |
| SRNE | Exit | SORRENTO THERAPEUTICS INC | $0 | – | -130,000 | -100.0% | -0.41% | – |
| AKAOQ | Exit | ACHAOGEN INC | $0 | – | -75,000 | -100.0% | -0.49% | – |
| NLNK | Exit | NEWLINK GENETICS CORP | $0 | – | -50,000 | -100.0% | -0.62% | – |
| Exit | IMPAX LABORATORIES INCput | $0 | – | -50,000 | -100.0% | -0.70% | – | |
| TSRO | Exit | TESARO INC | $0 | – | -50,000 | -100.0% | -0.73% | – |
| Exit | LIGAND PHARMACEUTICALS INCput | $0 | – | -25,000 | -100.0% | -0.73% | – | |
| Exit | SUPERNUS PHARMACEUTICALS INCcall | $0 | – | -150,000 | -100.0% | -0.77% | – | |
| DEPO | Exit | DEPOMED INC | $0 | – | -125,000 | -100.0% | -0.81% | – |
| Exit | ABBOTT LABScall | $0 | – | -50,000 | -100.0% | -0.95% | – | |
| Exit | EDWARDS LIFESCIENCES CORPput | $0 | – | -25,000 | -100.0% | -1.00% | – | |
| CI | Exit | CIGNA CORPORATION | $0 | – | -25,000 | -100.0% | -1.07% | – |
| TEVA | Exit | TEVA PHARMACEUTICAL INDS LTDadr | $0 | – | -50,000 | -100.0% | -1.22% | – |
| LGND | Exit | LIGAND PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -1.45% | – |
| Exit | VERTEX PHARMACEUTICALS INCcall | $0 | – | -35,000 | -100.0% | -1.55% | – | |
| STJ | Exit | ST JUDE MED INC | $0 | – | -52,500 | -100.0% | -1.70% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -25,000 | -100.0% | -1.82% | – |
| HZNP | Exit | HORIZON PHARMA INC | $0 | – | -255,000 | -100.0% | -1.88% | – |
| Exit | CELGENE CORPput | $0 | – | -50,000 | -100.0% | -2.00% | – | |
| Exit | PERRIGO CO PLCcall | $0 | – | -30,000 | -100.0% | -2.04% | – | |
| HCA | Exit | HCA HOLDINGS INC | $0 | – | -80,000 | -100.0% | -2.10% | – |
| Exit | SPDR S&P 500 ETF TRput | $0 | – | -25,000 | -100.0% | -2.28% | – | |
| Exit | ISHARESput | $0 | – | -75,000 | -100.0% | -4.16% | – | |
| Exit | AMGEN INCput | $0 | – | -82,500 | -100.0% | -4.56% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOGEN INC | 17 | Q1 2018 | 7.5% |
| ULTRAGENYX PHARMACEUTICAL IN | 17 | Q1 2018 | 6.7% |
| MERCK & CO INC NEW | 16 | Q1 2018 | 5.4% |
| CELGENE CORP | 15 | Q4 2017 | 7.9% |
| AERIE PHARMACEUTICALS INC | 15 | Q4 2017 | 3.3% |
| GILEAD SCIENCES INC | 14 | Q1 2017 | 6.7% |
| ESPERION THERAPEUTICS INC NE | 14 | Q1 2018 | 7.8% |
| SUPERNUS PHARMACEUTICALS INC | 14 | Q4 2017 | 2.8% |
| DERMIRA INC | 14 | Q1 2018 | 2.7% |
| AMGEN INC | 13 | Q1 2017 | 6.5% |
View Iguana Healthcare Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2018-05-15 |
| 13F-HR | 2018-02-14 |
| 13F-HR/A | 2017-11-16 |
| 13F-HR | 2017-11-14 |
| 13F-HR | 2017-08-14 |
| 13F-HR | 2017-05-15 |
| 13F-HR | 2017-02-14 |
| 13F-HR/A | 2016-11-17 |
| 13F-HR | 2016-11-14 |
| 13F-HR/A | 2016-11-04 |
View Iguana Healthcare Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.